·論 著·
孕婦外周血胎兒有核紅細(xì)胞與妊娠并發(fā)癥變化分析
王志宏1,邵雪齋1,李陳莉2*
(1.承德醫(yī)學(xué)院附屬醫(yī)院婦產(chǎn)科,河北承德067000;2.河北醫(yī)科大學(xué)基礎(chǔ)醫(yī)學(xué)院組織胚胎學(xué)教研室,河北石家莊050017)
目的探討妊娠期高血壓疾病、妊娠期糖尿病、妊娠合并血小板減少癥時(shí),母血中胎兒有核紅細(xì)胞(fetal nucleated red blood cell,F(xiàn)NRBC)數(shù)量的變化。方法選擇臨床確診的妊娠期高血壓疾病患者30例(其中子癇前期輕度12例,子癇前期重度12例,子癇6例),妊娠期糖尿病患者23例(其中血糖控制理想無低血糖或酮癥發(fā)生13例,血糖控制不理想曾發(fā)生低血糖或酮癥10例),妊娠合并血小板減少患者18例,另外選擇20例正常孕婦作為對(duì)照,分別取外周血進(jìn)行單密度梯度離心、瑞氏-姬姆薩染色和細(xì)胞計(jì)數(shù)。結(jié)果妊娠期高血壓疾病子癇前期輕度、子癇前期重度和發(fā)生子癇患者母血中FNRBC數(shù)量與對(duì)照組比較差異均有統(tǒng)計(jì)學(xué)意義(P<0.05);且子癇前期輕度、重度和發(fā)生子癇患者母血中FNRBC數(shù)量之間比較差異均有統(tǒng)計(jì)學(xué)意義(P<0.05)。妊娠期糖尿病患者母血中FNRBC數(shù)量與對(duì)照組比較差異有統(tǒng)計(jì)學(xué)意義(P<0.05);血糖控制理想不伴低血糖或酮癥發(fā)生患者母血中FNRBC數(shù)量與血糖控制不理想伴低血糖或酮癥發(fā)生的患者比較差異有統(tǒng)計(jì)學(xué)意義(P<0.05)。妊娠合并血小板減少患者母血中FNRBC數(shù)量與對(duì)照組比較差異無統(tǒng)計(jì)學(xué)意義(P>0.05)。結(jié)論 妊娠期高血壓疾病子癇前期和發(fā)生子癇患者以及妊娠期糖尿病患者母血中FNRBC數(shù)量增加,而且患者病情加重,母血中FNRBC數(shù)量增加更明顯。提示母血中FNRBC數(shù)量增加預(yù)示妊娠并發(fā)癥程度加重并威脅胎兒生命,應(yīng)積極采取干預(yù)措施,必要時(shí)終止妊娠。
妊娠并發(fā)癥;紅細(xì)胞;孕婦
孕婦外周血中存在胎兒有核紅細(xì)胞(fetal nucleated red blood cell,F(xiàn)NRBC),利用FNRBC進(jìn)行胎兒遺傳疾病的產(chǎn)前篩查是近年來國內(nèi)外新發(fā)展的一項(xiàng)非創(chuàng)傷性產(chǎn)前診斷技術(shù),因?yàn)檎T袐DFNRBC數(shù)量極少,母血中FNRBC的分離和富集以及與母源性紅細(xì)胞的鑒別一直是學(xué)者們在積極探索的問題。在不斷的臨床試驗(yàn)研究過程中,學(xué)者們發(fā)現(xiàn)有些病理妊娠如妊娠高血壓疾病子癇前期[1-2]、慢性胎兒宮內(nèi)窘迫[3]發(fā)生時(shí)母血中FNRBC數(shù)量增加。因此,母血中FNRBC增加在產(chǎn)前預(yù)測病理妊娠的發(fā)生及發(fā)病機(jī)制方面的研究引起廣大產(chǎn)科臨床醫(yī)師的關(guān)注。妊娠期高血壓疾病、妊娠期糖尿病、妊娠合并血小板減少癥是常見的威脅圍產(chǎn)期母兒健康的妊娠并發(fā)癥,本研究探討不同妊娠并發(fā)癥發(fā)生時(shí),母血中FNRBC的變化,旨在為母血中FNRBC計(jì)數(shù)在產(chǎn)前預(yù)測病理妊娠和無創(chuàng)性產(chǎn)前診斷中的應(yīng)用提供理論基礎(chǔ)和實(shí)驗(yàn)依據(jù)。
1.1 一般資料:選取2011年1月—2012年1月承德醫(yī)學(xué)院附屬醫(yī)院產(chǎn)科門診或病房住院確診的的妊娠并發(fā)癥患者71例,年齡23~35歲,孕周24~36周,根據(jù)病種不同分為3組。A組為妊娠期高血壓疾病患者30例;B組為妊娠期糖尿病患者23例;C組為妊娠合并血小板減少患者18例。每組根據(jù)患者疾病程度分為不同的亞組,其中A組分為3個(gè)亞組,A1組為子癇前期輕度12例,A2組為子癇前期重度12例,A3組為曾發(fā)生子癇6例;B組分為2個(gè)亞組,其中B1組為血糖控制理想無低血糖或酮癥發(fā)生的患者13例,B2組為血糖控制不理想曾發(fā)生低血糖或酮癥的患者10例。妊娠期高血壓疾病與妊娠期糖尿病診斷標(biāo)準(zhǔn)及分期標(biāo)準(zhǔn)依照人民衛(wèi)生出版社《婦產(chǎn)科學(xué)》第7版[4]。妊娠合并血小板減少患者外周血血小板計(jì)數(shù)<100×1012/L,血常規(guī)檢查其他項(xiàng)目正常,除外其他器質(zhì)性疾病以及其他并發(fā)癥。另外選取20例正常孕婦作為對(duì)照組,年齡23~35歲,孕周24~36周,經(jīng)嚴(yán)格體檢、監(jiān)測血壓,以及血尿常規(guī)、肝腎功能、電解質(zhì)、心電圖及B超等檢查均正常且排除其他器質(zhì)性疾病。以上各組年齡和孕周差異無統(tǒng)計(jì)學(xué)意義。
1.2 方法:所有患者均被告知且同意抽取靜脈血6mL,分別將各血樣進(jìn)行單密度梯度離心、瑞氏-姬姆薩染色和細(xì)胞計(jì)數(shù)。
1.3 統(tǒng)計(jì)學(xué)方法:應(yīng)用SPSS12.0軟件包做統(tǒng)計(jì)學(xué)分析,計(jì)量資料以±s表示,分別采用單因素方差分析和q檢驗(yàn)。P<0.05為差異有統(tǒng)計(jì)學(xué)意義。
2.1 FNRBC檢測情況:各組孕婦外周血中均檢測到FNRBC,見圖1。
圖1 胎兒有核紅細(xì)胞(瑞氏-姬姆薩染色 ×1 000)Figure 1 The fetal nucleated red blood cell(Wright-Giemsa staining ×1 000)
2.2 各組孕婦外周血FNRBC計(jì)數(shù)比較:妊娠期高
血壓疾病子癇前期輕度、子癇前期重度和發(fā)生子癇患者母血中FNRBC數(shù)量與對(duì)照組比較差異有統(tǒng)計(jì)學(xué)意義(P<0.05)。且子癇前期輕度、重度和發(fā)生子癇3組之間母血中FNRBC數(shù)量比較差異有統(tǒng)計(jì)學(xué)意義(P<0.05);妊娠期糖尿病患者母血中FNRBC數(shù)量與對(duì)照組比較差異有統(tǒng)計(jì)學(xué)意義(P<0.05),血糖控制理想不伴低血糖或酮癥發(fā)生的患者母血中FNRBC數(shù)量與血糖控制不理想伴低血糖或酮癥發(fā)生的患者比較差異有統(tǒng)計(jì)學(xué)意義(P<0.05)。妊娠合并血小板減少患者母血中FNRBC數(shù)量與對(duì)照組比較差異無統(tǒng)計(jì)學(xué)意義(P>0.05)。見表1。
表1 各組孕婦外周血胎兒有核紅細(xì)胞數(shù)目比較Table 1 The FNRBC number in maternal peripheral blood(±s,number/6mL)
表1 各組孕婦外周血胎兒有核紅細(xì)胞數(shù)目比較Table 1 The FNRBC number in maternal peripheral blood(±s,number/6mL)
*P<0.05 vs control group by q test
Groups n FNRBCnumber Control group 20 9.4±1.31 A1mild preeclampsia 12 11.5±1.09*A2 severe preeclampsia 12 21.0±1.41*A3 eclampsia 6 33.5±1.05*B1 GDM with ideal blood sugar control 13 10.8±1.14*B2 GDM with unsteady poorly blood sugar control 10 19.3±0.95*C thrombocytopenia 18 10.3±1.03*
本研究顯示妊娠期高血壓疾病子癇前期和發(fā)生子癇的患者以及妊娠期糖尿病的患者母血中FNRBC數(shù)量增加,而且患者病情加重時(shí)母血中FNRBC數(shù)量增加更明顯。
3.1 孕婦外周血FNRBC計(jì)數(shù)與胎兒缺氧:FNRBC是胎兒造血系統(tǒng)建立和發(fā)育過程中胎兒血液循環(huán)中出現(xiàn)的特征性細(xì)胞,缺氧刺激胎兒促紅細(xì)胞生成素增加以增加攜氧能力,因此血液中不成熟紅細(xì)胞增加,通過胎盤屏障進(jìn)入母血中的FNRBC計(jì)數(shù)增加。Troeger等[5]研究顯示子癇前期患者血漿激活素A濃度和促紅細(xì)胞生成素濃度均增加,從而使FNRBC增加,提示子癇前期患者存在潛在的胎盤功能低下,胎兒存在不同程度缺氧。Boskabadi等[6]研究顯示新生兒有核紅細(xì)胞百分?jǐn)?shù)和有核紅細(xì)胞的絕對(duì)值可作為評(píng)估圍產(chǎn)期胎兒(或新生兒)缺氧早期發(fā)病及嚴(yán)重程度的一項(xiàng)指標(biāo)。
3.2 孕婦外周血胎兒FNRBC計(jì)數(shù)與妊娠高血壓疾?。喝焉锔哐獕杭膊』镜牟±碜兓侨硇?dòng)脈痙攣,全身各系統(tǒng)各臟器灌流減少,因?yàn)樽訉m胎盤血流灌注減少引起胎兒缺氧,因此孕婦外周血胎兒FNRBC計(jì)數(shù)較正常增加。Aali等[1]研究顯示子癇前期孕婦外周血和胎兒臍血有核紅細(xì)胞比對(duì)照組顯著增加,而且孕婦外周血和臍血FNRBC數(shù)量有相關(guān)性。Bayram等[7]測定子癇前期胎兒臍血NRBC計(jì)數(shù)比對(duì)照組明顯增加。楊曉菊等[2]研究發(fā)現(xiàn)子癇前期可能存在著某種胎-母細(xì)胞傳輸紊亂機(jī)制,從而導(dǎo)致胎兒細(xì)胞漏入母體并與胎盤植入缺陷及滋養(yǎng)細(xì)胞不能有效侵入蛻膜層重鑄母體螺旋動(dòng)脈有關(guān),表明侵入母體的FNRBC數(shù)量與子癇前期的發(fā)生發(fā)展存在密切的聯(lián)系。本研究結(jié)果提示隨著孕婦外周血胎兒FNRBC計(jì)數(shù)明顯增加,妊娠高血壓疾病程度加重,胎兒缺氧程度加重。因此,在監(jiān)測血壓、尿蛋白、肝腎功能同時(shí)動(dòng)態(tài)檢測母血中FNRBC計(jì)數(shù),更有利于患者的分期診斷和治療,當(dāng)母血中FNRBC計(jì)數(shù)明顯增加時(shí),提示疾病程度加重,出現(xiàn)胎兒窘迫,需要及時(shí)給予解痙、降壓、鎮(zhèn)靜、吸氧等治療,必要時(shí)終止妊娠。
3.3 孕婦外周血胎兒FNRBC計(jì)數(shù)與妊娠期糖尿?。喝焉锲谔悄虿』颊咛ケP發(fā)生退行性病理改變[8-9]直接影響胎盤的供血和供氧功能,孕婦外周血和胎兒臍血中的促紅細(xì)胞生成素和胎兒FNRBC計(jì)數(shù)比非妊娠期糖尿病孕婦外周血中明顯增加[10]。由于孕婦空腹血糖較非孕時(shí)低,患有妊娠期糖尿病的孕婦如不及時(shí)監(jiān)測并控制血糖,容易出現(xiàn)低血糖或酮癥酸中毒。本研究提示妊娠期糖尿病患者母血中FNRBC數(shù)量增加,而當(dāng)動(dòng)態(tài)監(jiān)測到妊娠期糖尿病孕婦外周血中FNRBC計(jì)數(shù)明顯增加時(shí),提示血糖控制不理想,患者可能出現(xiàn)低血糖或酮癥等并發(fā)癥,胎兒已經(jīng)有缺氧存在,由于妊娠期糖尿病患者胎兒肺表面活性物質(zhì)合成不足,不能過早終止妊娠,應(yīng)給患者吸氧,嚴(yán)密監(jiān)測血糖,必要時(shí)注射胰島素,使血糖嚴(yán)格控制在正常范圍內(nèi),同時(shí)注意不要過分嚴(yán)格地控制飲食,以免出現(xiàn)低血糖或酮癥。
3.4 孕婦外周血胎兒NRBC計(jì)數(shù)與妊娠合并血小板減少:妊娠合并血小板減少最常見的原因是妊娠合并特發(fā)性血小板減少性紫癜(idiopathic thrombocytopenic purpura,ITP)和妊娠期血小板減少癥(gestational thrombocytopenia,GT),妊娠后發(fā)病的ITP與GT因臨床癥狀不明顯而不易鑒別,常表現(xiàn)單純血小板減少,患者孕期一般無臨床癥狀,如無其他并發(fā)癥,胎兒一般無缺氧表現(xiàn)。晁爽等[11]報(bào)道TP與GT患者胎兒早產(chǎn)率差異無統(tǒng)計(jì)學(xué)意義,而其他嚴(yán)重疾病繼發(fā)血小板減少患者新生兒異常增加。本研究提示患者外周血中FNRBC數(shù)量無明顯變化。
[1]AALI BS,MALEKPOUR R,SEDIG F,et al.Comparison of maternal and cord blood nucleated red blood cell count between pre-eclamptic and healthy women[J].J Obstet Gynaecol Res,2007,33(3):274-278.
[2]楊曉菊,趙金霞.重度子癇前期病人血清體液免疫狀況與外周血FNRBC水平關(guān)系[J].青島大學(xué)醫(yī)學(xué)院學(xué)報(bào),2011,47(2):113-114.
[3]張國榮,劉昕,董洪美,等.臍血乳酸及有核紅細(xì)胞測定與圍產(chǎn)期母兒缺氧的關(guān)系[J].中國優(yōu)生與遺傳雜志,2010,18(1):59,113.
[4]樂杰.婦產(chǎn)科學(xué)[M].7版.北京:人民衛(wèi)生出版社,2008:94.
[5]TROEGER C,HOLZGREVEW,LADEWIG A,et al.Examination ofmaternal plasma erythropoietin and activin A concentrations with regard to circulatory erythroblast levels in normal and preeclamptic pregnancies[J].Fetal Diagn Ther,2006,21(1):156-160.
[6]BOSKABADIH,MAAMOURIG,SADEGHIAN MH,et al.Early diagnosis of perinatal asphyxia by nucleated red blood cell count: a case-control study[J].Arch Iran Med,2010,13(4):275-281.
[7]BAYRAM F,OZERKAN K,CENGIZ C,et al.Perinatal asphyxia is associated with the umbilical cord nucleated red blood cell count in pre-eclamptic pregnancies[J].JObstet Gynaecol,2010,30(4):383-386.
[8]DASKALAKIS G,MARINOPOULOS S,KRIELESI V,et al.placental pathology in women with gestational diabetes[J].Acta Obstet Gynecol Scand,2008,87(4):403-407.
[9]米陽,郭娜,黃譜,等.妊娠期糖尿病胎盤超微結(jié)構(gòu)與胎兒生長異常的關(guān)系[J].中國實(shí)用婦科與產(chǎn)科雜志,2010,26(12):936-939.
[10]MADAZLI R,TUTEN A,CALAY Z,et al.The incidence of placental abnormalities, maternal and cord plasma malondialdehyde and vascular endothelial growth factor levels in women with gestational diabetesmellitus and nondiabetic controls[J].Gynecol Obstet Invest,2008,65(4):227-232.
[11]晁爽,曾超美,劉捷,等.妊娠合并血小板減少與新生兒轉(zhuǎn)歸的分析[J].中國當(dāng)代兒科雜志,2011,13(10):790-793.
(本文編輯:趙麗潔)
ANALYSISOF CHANGES BETWEEN FETAL NUCLEATED RED BLOOD CELL COUNT IN MATERNAL BLOOD AND PREGNANCY COMPLICATIONS
WANG Zhihong1,SHAO Xuezhai1,LIChenli2*
(1.Department of Gynecology and Obstetrics,Affiliated Hospital of Chengde Medical College,Hebei Province,Chengde 067000,China;2.Department of Histology and Embryology,the School of Basic Medical Sciences,Hebei Medical University,Shijiazhuang 050017,China)
Objective To investigate the changes of fetal nucleated red blood cells count(FNRBC)in peripheral blood of pregnant women with different pregnancy complications,such as hypertensive disorders in pregnancy,gestational diabetes mellitus(GDM)and pregnancy with thrombocytopenia.M ethods Thirty clinically diagnosed hypertensive disorders in pregnancy patients(12 casesmild preeclampsia,12 cases severe preeclampsia,6 cases eclampsia),23 cases GDM patients(13 cases blood sugar control ideal and without hypoglycemia or ketosis,10 cases whose blood sugar control was not ideal and ever occurred hypoglycemia or ketosis)and 18 cases pregnancy with thrombocytopenia patientswere analyzed in this study.Twenty cases normal pregnant women were taken as control at the same time.The peripheral blood of women in each group was obtained to count FNBRC and perform Wright-Giemsa stain after single density gradient centrifugation.Results There were significant differences in FNRBC number in peripheral blood of mild preeclampsia patients,severe preeclampsia patients and eclampsia patients compared with normal pregnant women in control group(P<0.05).
pregnancy complications;erythrocytes;pregnantwomen
R714.25
A
1007-3205(2013)03-0280-04
2012-06-04;
2012-09-16
王志宏(1967-),女,河北景縣人,承德醫(yī)學(xué)院附屬醫(yī)院副主任醫(yī)師,醫(yī)學(xué)碩士,從事婦產(chǎn)科疾病診治研究。
*通訊作者
10.3969/j.issn.1007-3205.2013.03.011
Moreover,there were significant differences in FNRBC number in peripheral blood of patients in 3 kinds of hypertensive disorders in pregnancy groups(P<0.05).The FNRBC number in peripheral blood of GDM patients had obvious differences compared with normal pregnant women in control group(P<0.05).In GDM group,the FNRBC number in peripheral blood of patients with ideal blood sugar control and without hypoglycemia or ketosis had obvious differences compared with patients with poorly blood sugar control and ever occurred hypoglycemia or ketosis(P<0.05).There was no significant difference in FNRBC number in peripheral blood of pregnancywith thrombocytopenia patients compared with normal pregnant women in control group(P>0.05).Conclusion The FNRBC number of preeclampsia patients,eclampsia patients and GDM patients increase;moreover,the increase of FNRBC number in maternal peripheral blood ismore obviouswhen illness is aggravated.The results suggest that increasing of FNRBC number can indicate aggravation of pregnancy complications and threat fetal life.Doctors should take effective interventions actively,and terminate pregnancy if necessary.